2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
70
TL;DR: In 2018, the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2018 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions as discussed by the authors .
read more
Abstract: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is high in middle and old age. The current practice guidelines will provide useful and sensible advice for the clinical management of patients with HCC. A total of 49 experts in the fields of hepatology, oncology, surgery, radiology, and radiation oncology from the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2018 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions. These guidelines provide useful information and direction for all clinicians, trainees, and researchers in the diagnosis and treatment of HCC.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide.
25 Mar 2024
TL;DR: Changing etiology and epidemiology of hepatocellular carcinoma: HCC is primarily caused by HBV infection, but the incidence of HCC related to NASH and NAFLD has increased worldwide.
42
Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
Yuri Cho,Jin Woo Choi,Hoon Kwon,Kun Yung Kim,Byung Chan Lee,Hee Ho Chu,Dong Hyeon Lee,Gyoung Min Kim,Jung Suk Oh,Dongho Hyun,In Joon Lee,Hyunchul Rhim +11 more
TL;DR: In this article , a group of 12 experts in the fields of interventional radiology and hepatology, convened by the Research Committee of the Korean Liver Cancer Association (KLCA), has developed expert consensus-based practical recommendations in TACE.
27
Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and MR imaging.
TL;DR: In this paper , the authors evaluated the prognostic value of microvascular invasion (MVI) classification and analyzed the radiologic features predictive of MVI in hepatocellular carcinoma (HCC) patients.
Radiologic features of hepatocellular carcinoma related to prognosis
Shin Hye Hwang,Hyungjin Rhee +1 more
TL;DR: Examination of imaging findings related to the prognosis of HCC as well as their associated clinicopathological characteristics is reviewed to decide the treatment strategy for HCC.
11
Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives
Joo Hyun Oh,Dong Hyun Sinn +1 more
TL;DR: Multidisciplinary approach for HCC management is promising, but lacks robust evidence and requires increased resources.
References
Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study.
Haruyuki Takaki,Koichiro Yamakado,Masakatsu Tsurusaki,Taku Yasumoto,Yasutaka Baba,Yoshiaki Narimatsu,Masashi Shimohira,Masato Yamaguchi,Kunihiro Matsuo,Yoshitaka Inaba,Koji Mikami,Ryohei Watanabe,Norifumi Nishida,Hiroshi Anai,Hideaki Kakizawa,Shozo Hirota +15 more
TL;DR: This HAIC provides promising therapeutic effects with acceptable safety to patients with intermediate-stage and advanced-stage HCCs and overall survival, progression-free survival, and safety.
12
Radiation Therapy and Palliative Care Prolongs the Survival of Hepatocellular Carcinoma Patients with Bone Metastases.
Masakuni Sakaguchi,Toshiya Maebayashi,Takuya Aizawa,Naoya Ishibashi,Shoko Fukushima,Tsutomu Saito +5 more
TL;DR: The present team approach in the hospital, which includes the provision of palliative care, started in 2007, may have improved prognosis of patients with metastatic HCC, and the median survival time of the patients who received care between 2007 and 2014 was 6 months, which was significantly longer than that in the patients between 2000 and 2006.
12
Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and Child-Pugh class A liver cirrhosis: A propensity score-matched comparison.
Gi-Won Song,Young-In Yoon,Gi-Won Song,Sung-Gyu Lee,Deok-Bog Moon,Shin Hwang,Woo-Hyoung Kang,Hwui-Dong Cho,Su-Min Ha,Min Jae Kim,Sanghoon Kim,Byeong-Gon Na,Geunhyeok Yang,Sung-Min Kim,Ju Hyun Shim,Jeong-Ik Park +15 more
TL;DR: In this paper, the authors compared survival outcomes and recurrence pattern following salvage living donor LT (LDLT) and repeat liver transplantation in patients with recurrent hepatocellular carcinoma (HCC).
12
Investigating the value of pre-treatment 18F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantation.
TL;DR: In this article, the authors investigated the value of pre-treatment 18F-FDG PET/CT in predicting the pathological characteristic of HCC and recurrence after liver transplantation (LT).
12
Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
Jong-In Chang,Dong Hyun Sinn,Hyun Sung Cho,Seonwoo Kim,Wonseok Kang,Geum-Youn Gwak,Yong-Han Paik,Moon Seok Choi,Joon Hyeok Lee,Kwang Cheol Koh,Seung Woon Paik +10 more
TL;DR: In this paper, the authors found that more than half of AVT-naive patients experienced HBV reactivation within three years, which was associated with increased risk of overall mortality.
12
Related Papers (5)
T. Hasegawa,Nobuyuki Takemura,Tatsuya Yamashita,Takeyuki Watadani,Masaki Kaibori,Shoji Kubo,M Shimada,Hiroaki Nagano,Etsuro Hatano,Hiroshi Aikata,Hiroko Iijima,Kazuomi Ueshima,Kazuyoshi Ohkawa,Takuya Genda,Kaoru Tsuchiya,Takuji Torimura,Masafumi Ikeda,Junji Furuse,Masaaki Akahane,Satoshi Kobayashi,Hideyuki Sakurai,Atsuya Takeda,Takamichi Murakami,Utaroh Motosugi,Yutaka Matsuyama,Masatoshi Kudo,Ryosuke Tateishi +26 more